Berlin - Delayed Quote EUR
BioNTech SE (22UA.BE)
86.80
-0.65
(-0.74%)
At close: 8:03:01 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-255,700
207,700
5,371,400
13,577,400
889,700
Investing Cash Flow
1,470,000
-2,081,200
-6,954,500
-35,300
-566,100
Financing Cash Flow
-51,900
-45,900
-778,600
-1,419,300
94,200
End Cash Position
10,139,000
9,761,900
11,663,700
13,875,100
1,692,700
Capital Expenditure
-933,500
-452,300
-705,500
-363,300
-154,000
Issuance of Capital Stock
--
0
0
110,500
160,900
Issuance of Debt
--
0
300
800
0
Repayment of Debt
-51,900
-45,900
-40,400
-59,900
-66,700
Repurchase of Capital Stock
--
0
-738,500
-986,400
0
Free Cash Flow
-1,189,200
-244,600
4,665,900
13,214,100
735,700
12/31/2021 - 10/15/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade